The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, ...
The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...
Natco Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives, Job Work, Scrap for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the ...